id | C00007298 |
---|---|
Name | Choline |
CAS RN | 62-49-7 |
Standard InChI | InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1 |
Standard InChI (Main Layer) | InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3 |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 5945 |
By standard InChI | CHEMBL920 |
---|---|
By standard InChI Main Layer | CHEMBL920 |
By LinkDB | C00114 |
---|
By CAS RN | D002794 |
---|
class name | count |
---|---|
rosids | 3 |
asterids | 1 |
eudicotyledons | 1 |
family name | count |
---|---|
Asteraceae | 1 |
Combretaceae | 1 |
Fabaceae | 1 |
Ranunculaceae | 1 |
Brassicaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Adonis vernalis L. | 46985 | Ranunculaceae | eudicotyledons | Viridiplantae |
Arabidopsis thaliana | 3702 | Brassicaceae | rosids | Viridiplantae |
Bauhinia candicans | 72379 | Fabaceae | rosids | Viridiplantae |
Combretum micranthum | 578542 | Combretaceae | rosids | Viridiplantae |
Onopordum acanthium | 92915 | Asteraceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL920 |
CHEMBL1741321
(1)
|
1 / 0 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | CHEMBL920 |
CHEMBL2077532
(1)
CHEMBL2076311
(1)
CHEMBL2077770 (1) CHEMBL2077776 (1) CHEMBL2077808 (1) |
0 / 0 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | CHEMBL920 |
CHEMBL993349
(1)
CHEMBL2076204
(1)
CHEMBL2077755 (1) CHEMBL2077767 (1) |
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL920 |
CHEMBL1741325
(1)
|
0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL920 |
CHEMBL1741322
(1)
|
0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL920 |
CHEMBL641238
(1)
|
1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL920 |
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL920 |
CHEMBL1741324
(1)
|
0 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL920 |
CHEMBL1738442
(1)
|
0 / 0 |
Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | CHEMBL920 |
CHEMBL2076168
(1)
|
1 / 1 |
O76082 | Solute carrier family 22 member 5 | Unclassified protein | CHEMBL920 |
CHEMBL2078080
(1)
CHEMBL2078086
(1)
|
1 / 2 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D002794 | 43 |
ACHE
ACEE ARACHE N-ACHE YT |
acetylcholinesterase (EC:3.1.1.7) | ACHE protein alternative form inhibits the reaction [Choline binds to CHRNA7 protein] |
affects binding
/ decreases reaction |
protein |
19287501
|
D002794 | 43 |
ACHE
ACEE ARACHE N-ACHE YT |
acetylcholinesterase (EC:3.1.1.7) | Choline analog results in decreased activity of ACHE protein |
decreases activity
|
protein |
17980356
|
D002794 | 8854 |
ALDH1A2
RALDH(II) RALDH2 RALDH2-T |
aldehyde dehydrogenase 1 family, member A2 (EC:1.2.1.36) | Choline affects the expression of ALDH1A2 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 64333 |
ARHGAP9
10C RGL1 |
Rho GTPase activating protein 9 | Choline affects the expression of ARHGAP9 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 590 |
BCHE
CHE1 CHE2 E1 |
butyrylcholinesterase (EC:3.1.1.8) | Choline analog results in decreased activity of BCHE protein |
decreases activity
|
protein |
17980356
|
D002794 | 701 |
BUB1B
BUB1beta BUBR1 Bub1A MAD3L MVA1 SSK1 hBUBR1 |
BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) | Choline affects the expression of BUB1B mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Choline affects the expression of CCL2 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 9332 |
CD163
M130 MM130 |
CD163 molecule | Choline affects the expression of CD163 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 948 |
CD36
BDPLT10 CHDS7 FAT GP3B GP4 GPIV PASIV SCARB3 |
CD36 molecule (thrombospondin receptor) | Choline affects the expression of CD36 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 55143 |
CDCA8
BOR BOREALIN DasraB MESRGP |
cell division cycle associated 8 | Choline affects the expression of CDCA8 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 55349 |
CHDH
|
choline dehydrogenase (EC:1.1.99.1) | CHDH gene SNP affects the susceptibility to Choline |
affects response to substance
|
gene |
17616785
|
D002794 | 1111 |
CHEK1
CHK1 |
checkpoint kinase 1 (EC:2.7.11.1) | Choline affects the expression of CHEK1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | Choline affects the activity of [CHRNA4 protein binds to CHRNB2 protein] |
affects activity
/ affects binding |
protein |
14645658
|
D002794 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | Choline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
14645658
|
D002794 | 1139 |
CHRNA7
CHRNA7-2 NACHRA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) | ACHE protein alternative form inhibits the reaction [Choline binds to CHRNA7 protein] |
affects binding
/ decreases reaction |
protein |
19287501
|
D002794 | 1139 |
CHRNA7
CHRNA7-2 NACHRA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) | Choline binds to and results in increased activity of CHRNA7 protein |
affects binding
/ increases activity |
protein |
12626641
|
D002794 | 1139 |
CHRNA7
CHRNA7-2 NACHRA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) | Choline binds to CHRNA7 protein |
affects binding
|
protein |
19287501
|
D002794 | 1139 |
CHRNA7
CHRNA7-2 NACHRA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) | Choline results in increased activity of CHRNA7 protein |
increases activity
|
protein |
10082212
|
D002794 | 1139 |
CHRNA7
CHRNA7-2 NACHRA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) | CHRNA7 protein mutant form results in increased susceptibility to Choline |
increases response to substance
|
protein |
10082212
|
D002794 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | Choline affects the activity of [CHRNA4 protein binds to CHRNB2 protein] |
affects activity
/ affects binding |
protein |
14645658
|
D002794 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | Choline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
14645658
|
D002794 | 81035 |
COLEC12
CLP1 NSR2 SCARA4 SRCL |
collectin sub-family member 12 | Choline affects the expression of COLEC12 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 1440 |
CSF3
C17orf33 CSF3OS GCSF G-CSF |
colony stimulating factor 3 (granulocyte) | [CSF3 protein co-treated with Paclitaxel] results in decreased abundance of Choline |
affects cotreatment
/ decreases abundance |
protein |
9018096
|
D002794 | 1471 |
CST3
ARMD11 |
cystatin C | Choline affects the expression of CST3 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 1514 |
CTSL
CATL CTSL1 MEP |
cathepsin L (EC:3.4.22.15) | Choline affects the expression of CTSL mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 1524 |
CX3CR1
CCRL1 CMKBRL1 CMKDR1 GPR13 GPRV28 V28 |
chemokine (C-X3-C motif) receptor 1 | Choline affects the expression of CX3CR1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 1794 |
DOCK2
|
dedicator of cytokinesis 2 | Choline affects the expression of DOCK2 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 3169 |
FOXA1
HNF3A TCF3A |
forkhead box A1 | Choline affects the expression of FOXA1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 2632 |
GBE1
APBD GBE GSD4 |
glucan (1,4-alpha-), branching enzyme 1 (EC:2.4.1.18) | Choline affects the expression of GBE1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 3003 |
GZMK
TRYP2 |
granzyme K (granzyme 3; tryptase II) (EC:3.4.21.-) | Choline affects the expression of GZMK mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 3309 |
HSPA5
BIP GRP78 MIF2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Choline affects the expression of HSPA5 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 396742 | Choline affects the expression of HSPCB mRNA |
affects expression
|
mRNA |
17616785
|
||
D002794 | 3560 |
IL2RB
CD122 IL15RB P70-75 |
interleukin 2 receptor, beta | Choline affects the expression of IL2RB mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 10112 |
KIF20A
MKLP2 RAB6KIFL |
kinesin family member 20A | Choline affects the expression of KIF20A mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 9493 |
KIF23
CHO1 KNSL5 MKLP-1 MKLP1 |
kinesin family member 23 | Choline affects the expression of KIF23 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 51348 |
KLRF1
CLEC5C NKp80 |
killer cell lectin-like receptor subfamily F, member 1 | Choline affects the expression of KLRF1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 114569 |
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) | Choline affects the expression of MAL2 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 55016 |
MARCH1
MARCH-I RNF171 |
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase | Choline affects the expression of MARCH1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 4256 |
MGP
MGLAP NTI |
matrix Gla protein | Choline affects the expression of MGP mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | Choline affects the expression of MMP2 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 4522 |
MTHFD1
MTHFC MTHFD |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (EC:1.5.1.5 6.3.4.3 3.5.4.9) | MTHFD1 gene SNP affects the susceptibility to Choline |
affects response to substance
|
gene |
17616785
|
D002794 | 9172 |
MYOM2
TTNAP |
myomesin 2 | Choline affects the expression of MYOM2 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Choline affects the expression of NFKBIA mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 11333 |
PDAP1
HASPP28 PAP PAP1 |
PDGFA associated protein 1 | Choline affects the expression of PDAP1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 10400 |
PEMT
PEAMT PEMPT PEMT2 PNMT |
phosphatidylethanolamine N-methyltransferase (EC:2.1.1.17 2.1.1.71) | PEMT gene SNP affects the susceptibility to Choline |
affects response to substance
|
gene |
17616785
|
D002794 | 5329 |
PLAUR
CD87 U-PAR UPAR URKR |
plasminogen activator, urokinase receptor | Choline affects the expression of PLAUR mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 10891 |
PPARGC1A
LEM6 PGC-1(alpha) PGC-1v PGC1 PGC1A PPARGC1 |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | Choline results in increased expression of PPARGC1A mRNA |
increases expression
|
mRNA |
23056435
|
D002794 | 23532 |
PRAME
CT130 MAPE OIP-4 OIP4 |
preferentially expressed antigen in melanoma | Choline affects the expression of PRAME mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 5790 |
PTPRCAP
CD45-AP LPAP |
protein tyrosine phosphatase, receptor type, C-associated protein | Choline affects the expression of PTPRCAP mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 10287 |
RGS19
GAIP RGSGAIP |
regulator of G-protein signaling 19 | Choline affects the expression of RGS19 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 57140 |
RNPEPL1
|
arginyl aminopeptidase (aminopeptidase B)-like 1 | Choline affects the expression of RNPEPL1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 6422 |
SFRP1
FRP FRP-1 FRP1 FrzA SARP2 |
secreted frizzled-related protein 1 | Choline affects the expression of SFRP1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 6584 |
SLC22A5
CDSP OCTN2 OCTN2VT |
solute carrier family 22 (organic cation/carnitine transporter), member 5 | Choline inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] |
decreases reaction
/ increases uptake |
protein |
16928358
|
D002794 | 9056 |
SLC7A7
LAT3 LPI MOP-2 Y+LAT1 y+LAT-1 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 | Choline affects the expression of SLC7A7 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 6594 |
SMARCA1
ISWI NURF140 SNF2L SNF2L1 SNF2LB SNF2LT SWI SWI2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | Choline affects the expression of SMARCA1 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 7015 |
TERT
CMM9 DKCA2 DKCB4 EST2 PFBMFT1 TCS1 TP2 TRT hEST2 hTRT |
telomerase reverse transcriptase (EC:2.7.7.49) | Choline affects the expression of TERT mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 7128 |
TNFAIP3
A20 OTUD7C TNFA1P2 |
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) | Choline affects the expression of TNFAIP3 mRNA |
affects expression
|
mRNA |
17616785
|
D002794 | 83549 |
UCK1
URK1 |
uridine-cytidine kinase 1 (EC:2.7.1.48) | Choline affects the expression of UCK1 mRNA |
affects expression
|
mRNA |
17616785
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000647 | D002794 | Amnesia |
therapeutic
|
20600432
|
|
D001321 | D002794 | Autistic Disorder |
marker/mechanism
|
16818868
|
|
D006528 | D002794 | Carcinoma, Hepatocellular |
marker/mechanism
therapeutic |
2387015
2396046 |
|
D003072 | D002794 | Cognition Disorders |
therapeutic
|
11823105
|
|
D003866 | D002794 | Depressive Disorder |
marker/mechanism
|
9018096
|
|
D002658 | D002794 | Developmental Disabilities |
marker/mechanism
|
16818868
|
|
D056486 | D002794 | Drug-Induced Liver Injury |
marker/mechanism
|
20548288
22330258 |
|
D005234 | D002794 | Fatty Liver |
marker/mechanism
therapeutic |
894741
17825453 20008134 20196952 20350562 20368703 20697377 23038002 |
|
D005235 | D002794 | Fatty Liver, Alcoholic |
therapeutic
|
20118189
|
|
D006505 | D002794 | Hepatitis |
marker/mechanism
|
20368703
|
|
D007249 | D002794 | Inflammation |
marker/mechanism
|
20008134
|
|
D007859 | D002794 | Learning Disorders |
therapeutic
|
20381573
|
|
D008103 | D002794 | Liver Cirrhosis |
marker/mechanism
|
17825453
20196952 |
|
D008113 | D002794 | Liver Neoplasms |
marker/mechanism
|
3554467
|
|
D008569 | D002794 | Memory Disorders |
therapeutic
|
20381573
|
|
C541083 | D002794 | Non-alcoholic Fatty Liver Disease |
marker/mechanism
|
20548288
|
|
D010195 | D002794 | Pancreatitis |
marker/mechanism
|
1713672
|
|
D016137 | D002794 | Spina Bifida Cystica |
therapeutic
|
22473653
|
|
D013226 | D002794 | Status Epilepticus |
marker/mechanism
|
1815138
3612132 |
|
D052878 | D002794 | Urolithiasis |
marker/mechanism
|
16941950
|